mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.001 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.002 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.003 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |